Skip to main content
Hugel, Inc. logo

Hugel, Inc. — Investor Relations & Filings

Ticker · 145020 ISIN · KR7145020004 KO Manufacturing
Open in API
Filings indexed 500 across all filing types
Latest filing 2026-06-01 Regulatory Filings
Country KR South Korea
Listing KO 145020

About Hugel, Inc.

https://www.hugel-inc.com/

Hugel, Inc. is a global biopharmaceutical company specializing in the medical aesthetics and therapeutics market. The company develops, manufactures, and distributes a portfolio of high-quality products, including its flagship botulinum toxin type A formulations, known commercially as Botulax and Letybo. Its product line also features a range of hyaluronic acid (HA) fillers and PDO threads. Recognized as a leader in its field, Hugel is focused on providing innovative, efficient, and proven solutions to medical professionals worldwide. The company is committed to advancing aesthetic medicine through continuous research and development to create effective and reliable treatments.

Recent filings

Filing Released Lang Actions
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Regulatory Filings Classification · 85% confidence The document is an annual conglomerate group status disclosure (“기업집단현황공시”) under Korean regulatory requirements, listing corporate group structure, financials, board and committee operations, intercompany transactions, and shareholder information. It is a statutory regulatory filing rather than a management discussion, earnings release, or annual report itself. It does not present full audited statements as an annual report nor is it a simple announcement of another report. It fits as a general regulatory disclosure, so it is classified as Regulatory Filings (RNS).
2026-06-01 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” (Quarterly Report), covers the 26th fiscal term for the period 2026-01-01 to 2026-03-31, and contains detailed financial statements, segment breakdowns, corporate overview, and substantive financial data. This matches the definition of an Interim/Quarterly Report. Q1 2026
2026-05-15 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 95% confidence The document is a Korean ‘주식등의 대량보유상황보고서(약식)’ detailing holdings and changes in share ownership by a major investor, including threshold crossings and number of shares held. This matches the Major Shareholding Notification category.
2026-05-13 Korean
주식매수선택권부여에관한신고
Director's Dealing Classification · 95% confidence The document is a notification regarding the granting of stock options (주식매수선택권 부여에 관한 신고) by the company 휴젤(주). It includes details such as the number of shares granted, exercise conditions, fair value calculation using the Black-Scholes model, and references to relevant laws and board resolutions. The document is addressed to regulatory bodies (금융위원회/한국거래소) and is a formal disclosure of a stock option grant. This type of filing corresponds to a Director's Dealing or insider-related transaction, specifically the granting of stock options to directors, executives, or employees. It is not a financial report, earnings release, or general regulatory announcement but a specific insider transaction disclosure. Therefore, the appropriate classification is Director's Dealing (DIRS). The document length is short and focused on this specific transaction, supporting this classification with high confidence.
2026-05-07 Korean
주주총회소집결의 (임시주주총회)
AGM Information Classification · 95% confidence The document is a notice of convening a shareholders' meeting (임시주주총회, or extraordinary general meeting) with details such as date, time, and agenda to be decided later. It is not a report or presentation but an official announcement to shareholders about the meeting. The document length is short (706 characters), and it primarily serves to inform about the meeting's scheduling and procedural details. Therefore, it fits the category of AGM Information (AGM-R), which covers materials shared during general meetings, including notices of meeting convening.
2026-05-07 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the setting of the shareholder register closure period or record date for an upcoming extraordinary general meeting. It includes specific dates and references the company's articles of incorporation and relevant laws. The document length is only 624 characters, indicating it is a brief notice rather than a full report. It does not contain financial data or detailed report content. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2026-05-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.